It would be natural for such studies to focus on immunohistochemical detection of LRP2, which we previously demonstrated to be useful for the analysis of melanoma tumors [29] and, in the present study, for the analysis of invasive breast carcinomas. This evidence concerns the gene LRP2 and invasive breast carcinoma.